Limited Coverage Drugs - tocilizumab for the treatment of GCA

Generic Name



162 mg/0.9 mL


pre-filled syringe

Special Authority Criteria

Approval Period

For the treatment of Giant Cell Arteritis (GCA) according to criteria detailed in Special Authority Request form HLTH 5496 and when prescribed by a rheumatologist or ophthalmologist.

1 year

Practitioner Exemptions

  • No practitioner exemptions.

Special Authority Request Form